Concepedia

Markus Joerger

MJ

114

Publications

5.7K

Citations

43

H-Index

2002

Active since

Affiliations

University of St.Gallen(Current)

Kantonsspital St. Gallen

The Netherlands Cancer Institute

Utrecht University

University Hospital of Bern

Markus Joerger is an author at University of St.Gallen specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2002–2024

114

Publications

114

Rapid mass spectrometric conversion of tissue biopsy samples into permanent quantitative digital proteome maps

Tiannan Guo, Petri Kouvonen, Ching Chiek Koh et al. · Nature Medicine · 2015 · 396 citations · Full text

, , +9

SAKK 16/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non–Small-Cell Lung Cancer—A Multicenter Single-Arm Phase II Trial

Sacha I. Rothschild, Alfred Zippelius, E.I. Eboulet et al. · Journal of Clinical Oncology · 2021 · 336 citations

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Oliver Gautschi, Colette Bigosch, Barbara Huegli et al. · Journal of Clinical Oncology · 2004 · 286 citations · Full text

Rogaratinib in patients with advanced cancers selected by FGFR mRNA expression: a phase 1 dose-escalation and dose-expansion study

Martin Schüler, Byoung Chul Cho, Cyrus Sayehli et al. · The Lancet Oncology · 2019 · 161 citations

, , +8

Randomized Phase II and Pharmacogenetic Study of Pemetrexed Compared With Pemetrexed Plus Carboplatin in Pretreated Patients With Advanced Non–Small-Cell Lung Cancer

Egbert F. Smit, Sjaak A. Burgers, Bonne Biesma et al. · Journal of Clinical Oncology · 2009 · 151 citations · Full text

Rows per page

1–5 of 114